Egetis Therapeutics (Sweden) Market Value
| EGTX Stock | SEK 5.61 0.21 3.89% |
| Symbol | Egetis |
Egetis Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Egetis Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Egetis Therapeutics.
| 12/12/2022 |
| 12/01/2024 |
If you would invest 0.00 in Egetis Therapeutics on December 12, 2022 and sell it all today you would earn a total of 0.00 from holding Egetis Therapeutics AB or generate 0.0% return on investment in Egetis Therapeutics over 720 days. Egetis Therapeutics is related to or competes with Hansa Biopharma, Saniona AB, and Oncopeptides. Egetis Therapeutics AB , a pharmaceutical drug development company, focuses on projects in late-stage development for th... More
Egetis Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Egetis Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Egetis Therapeutics AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.27 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 28.58 | |||
| Value At Risk | (5.00) | |||
| Potential Upside | 6.76 |
Egetis Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Egetis Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Egetis Therapeutics' standard deviation. In reality, there are many statistical measures that can use Egetis Therapeutics historical prices to predict the future Egetis Therapeutics' volatility.| Risk Adjusted Performance | 0.0144 | |||
| Jensen Alpha | (0.09) | |||
| Total Risk Alpha | (0.68) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | 0.0261 |
Egetis Therapeutics Backtested Returns
Currently, Egetis Therapeutics AB is relatively risky. Egetis Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0082, which denotes the company had a 0.0082% return per unit of risk over the last 3 months. We have found thirty technical indicators for Egetis Therapeutics AB, which you can use to evaluate the volatility of the firm. Please confirm Egetis Therapeutics' Downside Deviation of 3.27, coefficient of variation of 12257.1, and Mean Deviation of 2.86 to check if the risk estimate we provide is consistent with the expected return of 0.0343%. The firm shows a Beta (market volatility) of 0.93, which means possible diversification benefits within a given portfolio. Egetis Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Egetis Therapeutics is expected to follow. Egetis Therapeutics right now shows a risk of 4.21%. Please confirm Egetis Therapeutics semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and standard deviation , to decide if Egetis Therapeutics will be following its price patterns.
Auto-correlation | 0.31 |
Below average predictability
Egetis Therapeutics AB has below average predictability. Overlapping area represents the amount of predictability between Egetis Therapeutics time series from 12th of December 2022 to 7th of December 2023 and 7th of December 2023 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Egetis Therapeutics price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current Egetis Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.31 | |
| Spearman Rank Test | 0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 1.05 |
Egetis Therapeutics lagged returns against current returns
Autocorrelation, which is Egetis Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Egetis Therapeutics' stock expected returns. We can calculate the autocorrelation of Egetis Therapeutics returns to help us make a trade decision. For example, suppose you find that Egetis Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Egetis Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Egetis Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Egetis Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Egetis Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Egetis Therapeutics Lagged Returns
When evaluating Egetis Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Egetis Therapeutics stock have on its future price. Egetis Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Egetis Therapeutics autocorrelation shows the relationship between Egetis Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Egetis Therapeutics AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Egetis Stock Analysis
When running Egetis Therapeutics' price analysis, check to measure Egetis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Egetis Therapeutics is operating at the current time. Most of Egetis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Egetis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Egetis Therapeutics' price. Additionally, you may evaluate how the addition of Egetis Therapeutics to your portfolios can decrease your overall portfolio volatility.